title: Remission of aHUS neurological damage with eculizumab.
abstract: Atypical haemolytic uraemic syndrome (aHUS) is a rare disease characterized by haemolytic microangiopathic anaemia, thrombocytopaenia and acute onset of renal failure, in the absence of Escherichia coli infection. Renal damage usually progresses to end-stage renal disease (ESRD), sometimes being accompanied by signs of extrarenal thrombotic microangiopathy (TMA). We report a case of full neurological and haematological recovery after eculizumab treatment in a patient with ESRD secondary to chronic aHUS refractory to plasmatherapy while she was under dialysis. It highlights the use of eculizumab for controlling extrarenal manifestations of aHUS in this population.
authors: Department of Nephrology , Hospital Universitario Dr Peset , Valencia , Spain.
authors: Ana
authors: A
authors: Ávila
authors: Department of Nephrology , Hospital Universitario Dr Peset , Valencia , Spain.
authors: Belén
authors: B
authors: Vizcaíno
authors: Department of Nephrology , Hospital Universitario Dr Peset , Valencia , Spain.
authors: Pablo
authors: P
authors: Molina
authors: Department of Nephrology , Hospital Universitario Dr Peset , Valencia , Spain.
authors: Eva
authors: E
authors: Gavela
authors: Department of Pathology , Universitario Dr Peset Hospital , Valencia , Spain.
authors: Maria
authors: M
authors: Perez-Ebri
authors: Department of Nephrology , Hospital Universitario Dr Peset , Valencia , Spain.
authors: Luís
authors: L
authors: Pallardó
keywords: atypical haemolytic uraemic syndrome; eculizumab; neurologic involvement; plasma exchange; thrombotic microangiopathy